|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gill K, Kirma N, Gunna VS, Santanam N,
Parthasarathy S and Tekmal RR: Regulation of colony stimulating
factor-1 (CSF-1) in endometrial cells: Glucocorticoids and
oxidative stress regulate the expression of CSF-1 and its receptor
c-fms in endometrial cells. Fertil Steril. 76:1005–1011. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pixley FJ and Stanley ER: CSF-1 regulation
of the wandering macrophage: Complexity in action. Trends Cell
Biol. 14:628–638. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang L, Wu Q, Xu L, Zhang W, Zhu Y, Liu H,
Xu J and Gu J: Increased expression of colony stimulating factor-1
is a predictor of poor prognosis in patients with clear-cell renal
cell carcinoma. BMC Cancer. 15:672015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Komohara Y, Ohnishi K, Kuratsu J and
Takeya M: Possible involvement of the M2 anti-inflammatory
macrophage phenotype in growth of human gliomas. J Pathol.
216:15–24. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Patsialou A, Wyckoff J, Wang Y, Goswami S,
Stanley ER and Condeelis JS: Invasion of human breast cancer cells
in vivo requires both paracrine and autocrine loops involving the
colony-stimulating factor-1 receptor. Cancer Res. 69:9498–9506.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Soares MJ, Pinto M, Henrique R, Vieira J,
Cerveira N, Peixoto A, Martins AT, Oliveira J, Jerónimo C and
Teixeira MR: CSF1R copy number changes, point mutations, and RNA
and protein overexpression in renal cell carcinomas. Mod Pathol.
22:744–752. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ide H, Seligson DB, Memarzadeh S, Xin L,
Horvath S, Dubey P, Flick MB, Kacinski BM, Palotie A and Witte ON:
Expression of colony-stimulating factor 1 receptor during prostate
development and prostate cancer progression. Proc Natl Acad Sci
USA. 99:14404–14409. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chambers SK, Kacinski BM, Ivins CM and
Carcangiu ML: Overexpression of epithelial macrophage
colony-stimulating factor (CSF-1) and CSF-1 receptor: A poor
prognostic factor in epithelial ovarian cancer, contrasted with a
protective effect of stromal CSF-1. Clin Cancer Res. 3:999–1007.
1997.PubMed/NCBI
|
|
11
|
Komohara Y, Hasita H, Ohnishi K, Fujiwara
Y, Suzu S, Eto M and Takeya M: Macrophage infiltration and its
prognostic relevance in clear cell renal cell carcinoma. Cancer
Sci. 102:1424–1431. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hung JY, Horn D, Woodruff K, Prihoda T,
LeSaux C, Peters J, Tio F and Abboud-Werner SL: Colony-stimulating
factor 1 potentiates lung cancer bone metastasis. Lab Invest.
94:371–381. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Goswami S, Sahai E, Wyckoff JB, Cammer M,
Cox D, Pixley FJ, Stanley ER, Segall JE and Condeelis JS:
Macrophages promote the invasion of breast carcinoma cells via a
colony-stimulating factor-1/epidermal growth factor paracrine loop.
Cancer Res. 65:5278–5283. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Menke J, Kriegsmann J, Schimanski CC,
Schwartz MM, Schwarting A and Kelley VR: Autocrine CSF-1 and CSF-1
receptor coexpression promotes renal cell carcinoma growth. Cancer
Res. 72:187–200. 2012. View Article : Google Scholar
|
|
15
|
Okugawa Y, Toiyama Y, Hur K, Toden S,
Saigusa S, Tanaka K, Inoue Y, Mohri Y, Kusunoki M, Boland CR, et
al: Metastasis-associated long non-coding RNA drives gastric cancer
development and promotes peritoneal metastasis. Carcinogenesis.
35:2731–2739. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Okugawa Y, Tanaka K, Inoue Y, Kawamura M,
Kawamoto A, Hiro J, Saigusa S, Toiyama Y, Ohi M, Uchida K, et al:
Brain-derived neurotrophic factor/tropomyosin-related kinase B
pathway in gastric cancer. Br J Cancer. 108:121–130. 2013.
View Article : Google Scholar :
|
|
17
|
Okugawa Y, Inoue Y, Tanaka K, Kawamura M,
Saigusa S, Toiyama Y, Ohi M, Uchida K, Mohri Y and Kusunoki M: Smad
interacting protein 1 (SIP1) is associated with peritoneal
carcinomatosis in intestinal type gastric cancer. Clin Exp
Metastasis. 30:417–429. 2013. View Article : Google Scholar
|
|
18
|
Okugawa Y, Toiyama Y, Tanaka K, Matsusita
K, Fujikawa H, Saigusa S, Ohi M, Inoue Y, Mohri Y, Uchida K, et al:
Clinical significance of Zinc finger E-box Binding homeobox 1
(ZEB1) in human gastric cancer. J Surg Oncol. 106:280–285. 2012.
View Article : Google Scholar
|
|
19
|
Toiyama Y, Tanaka K, Kitajima T, Shimura
T, Imaoka H, Mori K, Okigami M, Yasuda H, Okugawa Y, Saigusa S, et
al: Serum angiopoietin-like protein 2 as a potential biomarker for
diagnosis, early recurrence and prognosis in gastric cancer
patients. Carcinogenesis. 36:1474–1483. 2015.PubMed/NCBI
|
|
20
|
Toiyama Y, Yasuda H, Saigusa S, Matushita
K, Fujikawa H, Tanaka K, Mohri Y, Inoue Y, Goel A and Kusunoki M:
Co-expression of hepatocyte growth factor and c-Met predicts
peritoneal dissemination established by autocrine hepatocyte growth
factor/c-Met signaling in gastric cancer. Int J Cancer.
130:2912–2921. 2012. View Article : Google Scholar
|
|
21
|
Japanese-Gastric-Cancer-Association: Jpn
Classificacion Gastric Carcinoma. 14:10–25. 2010.
|
|
22
|
Tanaka K, Mohri Y, Nishioka J, Kobayashi
M, Ohi M, Miki C, Tonouchi H, Nobori T and Kusunoki M: Neurotrophic
receptor, tropomyosin-related kinase B as an independent prognostic
marker in gastric cancer patients. J Surg Oncol. 99:307–310. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Conway JG, McDonald B, Parham J, Keith B,
Rusnak DW, Shaw E, Jansen M, Lin P, Payne A, Crosby RM, et al:
Inhibition of colony-stimulating-factor-1 signaling in vivo with
the orally bioavailable cFMS kinase inhibitor GW2580. Proc Natl
Acad Sci USA. 102:16078–16083. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Conway JG, Pink H, Bergquist ML, Han B,
Depee S, Tadepalli S, Lin P, Crumrine RC, Binz J, Clark RL, et al:
Effects of the cFMS kinase inhibitor
5-(3-methoxy-4-((4-methoxybenzyl)oxy)benzyl) pyrimidine-2,4-diamine
(GW2580) in normal and arthritic rats. J Pharmacol Exp Ther.
326:41–50. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Okugawa Y, Toiyama Y, Toden S, Mitoma H,
Nagasaka T, Tanaka K, Inoue Y, Kusunoki M, Boland CR and Goel A:
Clinical significance of SNORA42 as an oncogene and a prognostic
biomarker in colorectal cancer. Gut. 66:107–117. 2017. View Article : Google Scholar
|
|
26
|
Frisch SM and Francis H: Disruption of
epithelial cell-matrix interactions induces apoptosis. J Cell Biol.
124:619–626. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Eccles SA and Welch DR: Metastasis: Recent
discoveries and novel treatment strategies. Lancet. 369:1742–1757.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Richardsen E, Uglehus RD, Due J, Busch C
and Busund LT: The prognostic impact of M-CSF, CSF-1 receptor, CD68
and CD3 in prostatic carcinoma. Histopathology. 53:30–38. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Espinosa I, Beck AH, Lee CH, Zhu S,
Montgomery KD, Marinelli RJ, Ganjoo KN, Nielsen TO, Gilks CB, West
RB, et al: Coordinate expression of colony-stimulating factor-1 and
colony-stimulating factor-1-related proteins is associated with
poor prognosis in gynecological and nongynecological
leiomyosarcoma. Am J Pathol. 174:2347–2356. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yu W, Chen J, Xiong Y, Pixley FJ, Yeung YG
and Stanley ER: Macrophage proliferation is regulated through CSF-1
receptor tyrosines 544, 559, and 807. J Biol Chem. 287:13694–13704.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chitu V and Stanley ER: Colony-stimulating
factor-1 in immunity and inflammation. Curr Opin Immunol. 18:39–48.
2006. View Article : Google Scholar
|
|
32
|
Sherr CJ, Rettenmier CW, Sacca R, Roussel
MF, Look AT and Stanley ER: The c-fms proto-oncogene product is
related to the receptor for the mononuclear phagocyte growth
factor, CSF-1. Cell. 41:665–676. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lin EY, Nguyen AV, Russell RG and Pollard
JW: Colony-stimulating factor 1 promotes progression of mammary
tumors to malignancy. J Exp Med. 193:727–740. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Aharinejad S, Abraham D, Paulus P, Abri H,
Hofmann M, Grossschmidt K, Schäfer R, Stanley ER and Hofbauer R:
Colony-stimulating factor-1 antisense treatment suppresses growth
of human tumor xenografts in mice. Cancer Res. 62:5317–5324.
2002.PubMed/NCBI
|
|
35
|
Wyckoff J, Wang W, Lin EY, Wang Y, Pixley
F, Stanley ER, Graf T, Pollard JW, Segall J and Condeelis J: A
paracrine loop between tumor cells and macrophages is required for
tumor cell migration in mammary tumors. Cancer Res. 64:7022–7029.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fidler IJ: Critical determinants of
metastasis. Semin Cancer Biol. 12:89–96. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chan DA and Giaccia AJ: Hypoxia, gene
expression, and metastasis. Cancer Metastasis Rev. 26:333–339.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Curry JM, Eubank TD, Roberts RD, Wang Y,
Pore N, Maity A and Marsh CB: M-CSF signals through the MAPK/ERK
pathway via Sp1 to induce VEGF production and induces angiogenesis
in vivo. PLoS One. 3:e34052008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Eubank TD, Galloway M, Montague CM,
Waldman WJ and Marsh CB: M-CSF induces vascular endothelial growth
factor production and angiogenic activity from human monocytes. J
Immunol. 171:2637–2643. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Okazaki T, Ebihara S, Takahashi H, Asada
M, Kanda A and Sasaki H: Macrophage colony-stimulating factor
induces vascular endothelial growth factor production in skeletal
muscle and promotes tumor angiogenesis. J Immunol. 174:7531–7538.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zins K, Abraham D, Sioud M and Aharinejad
S: Colon cancer cell-derived tumor necrosis factor-alpha mediates
the tumor growth-promoting response in macrophages by up-regulating
the colony-stimulating factor-1 pathway. Cancer Res. 67:1038–1045.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Aharinejad S, Salama M, Paulus P, Zins K,
Berger A and Singer CF: Elevated CSF1 serum concentration predicts
poor overall survival in women with early breast cancer. Endocr
Relat Cancer. 20:777–783. 2013. View Article : Google Scholar : PubMed/NCBI
|
